biopsies all normal. Antinuclear factor negative. Thyroid cytoplasmic antibodies negative. No LE cells found in several preparations. Thyroglobulin antibody titre I : 5; sheep cell agglutination titre 1:16.
Treatment was started with prednisone. However, she developed hypertension and is now also receiving methyldopa. Despite this her respiratory function is continuing to deteriorate.
Fig I Chest X-ray showing wvidespreadpatchy shadowing Discussion
The condition of interstitial pulmonary fibrosis was originally described by Hamman & Rich (I1944) Initially there is infiltration of the alveolar walls with mononuclearcells andreticulin followed later by fibrosis and scarring, leading to respiratory failure and pulmonary hypertension. The condition may occur at any age and the duration is very variable. In the patients described initially the disease was confined to the lungs. However, Rubin & Lubliner (1957) , Ellman (1956) and others have shown that very similar lung lesions occur in such collagen diseases as lupus erythematosus and dermatomyositis. The fact that the lesions often respond to steroid therapy and that experimentally in rats similar lesions can be produced with anti-rat-lung s'erum (Read 1958) also adds support to the theory that autoimmune processes play an important part in the ietiology of this condition.
Our patient also had an attack of encephalitis causing permanent brain damage and it seems most likely that this was an acute allergic encephalopathy. This may be one of the manifestations of lupus erythematosus (Vessasiva 1965 ).
The hepatosplenomegaly, anamia and thrombocytopenia with which our patient presented originally would also favour this diagnosis (Larson 1961 50 g of iron being given to the boy, compared to less than 4 5 g within the body of a normal male adult. About this time, he developed increasing dyspnoea with chest pain. He was found to be deeply pigmented with evidence of right and left heart failure. Electrocardiographs showed a prolonged P-R interval with flattening of the T waves. He was considered to have hamosiderosis affecting the myocardium and probably also the conducting tissue. Response to digoxin and diuretics was impressive.
In October 1964, he developed a sudden leftsided hemiparesis associated with progressive difficulty in speech and swallowing. Right hemiparesis followed soon afterwards. He made excellent progress subsequently but is still left with residual right-sided weakness -presumably the cerebrovascular accidentswere due to emboli from intraventricular thrombi. Chelation therapy, using desferrioxamine intravenously and intramuscularly, is now being pursued.
Comment
This patient resembles in most aspects the pure red cell anemia first mentioned by Josephs (1936) and later described in more detail by Diamond & Blackfan (1938) . In an extensive review, Diamond et al. (1961) emphasized the possibility of spontaneous remissions even after many years of transfusions, and remarked on the significant correlation between the duration of the disease before therapy and its response to steroids. The longer the anemia had existed before treatment, the less likely was it to respond. All their cases treated within three months of onset responded.
Complications which develop in these patients are usually related to the anemia itself, to splenectomy, or to the secondary hemosiderosis resulting from repeated transfusions. Clinical findings in hemosiderosis include skin pigmentation and hepatomegaly, but liver failure and portal hypertension rarely occur. Cardiac complications similar to those in hiemochromatosis also occur, though are less frequently mentioned. Presumably the complications are related to iron deposits in the myocardium and to the sub-endocardial fibrosis.
The clinical picture is of progressive right-sided heart failure. Pericarditis may occur. Extrasystoles, various tachycardias and atrioventricular block are also seen.
Any drugs therefore able to chelate enough iron in these patients would indeed be useful. Desferrioxamine and DTPA are at present the most impressive.
Dr R M Hardisty thought it would be well worth while treating this boy intensively with iron-chelating agents. Sephton Smith (1964 Ann. N.Y. Acad. Sci. 119, 776) working in Dr Hardisty's department, had shown that the iron excretion produced by these agents increased with the degree of iron overload as measured by the degree of saturation of plasma ironbinding capacity. He had found that as much as 100-200 mg of iron could be removed by a single dose of 4 g DTPA given intravenously at the time of transfusion to a patient with severe transfusion hemosiderosis, and 5-15 mg daily by the intramuscular administration of 0 5 g of desferrioxamine. In this way perhaps about 3-5 g of iron could be removed in one year from a patient such as this by intensive therapy-an amount of the same order, or perhaps exceeding, that received in the form of blood transfusion. Among the patients they had been treating during the last few years had been a boy with erythrogenesis imperfecta, who had been heavily overloaded with iron at the age of 14, but had subsequently lost his skin pigmentation after three years' treatment with chelating agents.
Congenital Aneutrocytosis J M Ibrahim MRCPEd DCH K J, boy, aged 4 months. First child of a 19-yearold English mother and a Jamaican father History: Presented with fever, macular rash, generalized lymphadenopathy, hepatosplenomegaly and meningism. There was a preceding history of chest infection, a boil on th-e leg and styes.
Investigations: Peripheral blood showed Hb 9 g/100 ml, WBC 10,000 (neutros. 1 %, monos. 60%%), platelets normal, reticulocytes less than 0'5 %, ESR 60 mm in 1 hour (Westergren). CSF normal; X-rays of chest, long bones and skull normal. Total plasma proteins 6-6, albumin 4-4, globulin 2-2, y-globulin 0'73 g/100 ml. The following tests were negative: Paul-Bunnell (four occasions), blood culture, toxoplasma dye test, Mantoux down to 1/100, Wassermann reaction, cytomegalic inclusion bodies in urine and LE cells
